Description:

Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum https://clinicaltrials.gov/ct2/show/NCT00077233

Link:

https://clinicaltrials.gov/ct2/show/NCT00077233

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 7/14/17
Uploaded on:

July 14, 2017

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Metastatic Colorectal Cancer Fluorouracil Leucovorin Irinotecan Oxaliplatin NCT00077233 CALGB 80203

No Instruction available.

  1. StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
    1. No Instruction available.
Header
Are data amended
Cetuximab Skin Toxicities
Mark with an X if there are none
Adverse event term
Adverse event grade
Cetuximab Dose Modification
If ongoing mark with an X

Similar models